ro 32-0432 has been researched along with adenosine-5'-(n-ethylcarboxamide) in 1 studies
| Studies (ro 32-0432) | Trials (ro 32-0432) | Recent Studies (post-2010) (ro 32-0432) | Studies (adenosine-5'-(n-ethylcarboxamide)) | Trials (adenosine-5'-(n-ethylcarboxamide)) | Recent Studies (post-2010) (adenosine-5'-(n-ethylcarboxamide)) |
|---|---|---|---|---|---|
| 56 | 0 | 13 | 1,333 | 4 | 133 |
| Protein | Taxonomy | ro 32-0432 (IC50) | adenosine-5'-(n-ethylcarboxamide) (IC50) |
|---|---|---|---|
| Adenosine receptor A3 | Homo sapiens (human) | 0.0097 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.4498 | |
| Adenosine receptor A2a | Homo sapiens (human) | 0.0336 | |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.0175 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0007 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.0513 | |
| Adenosine receptor A1 | Gallus gallus (chicken) | 0.017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francis, K; Ham, J; Lewis, BM; Lewis, MD; Rees, DA; Scanlon, MF | 1 |
1 other study(ies) available for ro 32-0432 and adenosine-5'-(n-ethylcarboxamide)
| Article | Year |
|---|---|
Adenosine-induced IL-6 expression in pituitary folliculostellate cells is mediated via A2b adenosine receptors coupled to PKC and p38 MAPK.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Androstadienes; Animals; Cells, Cultured; Dexamethasone; Estrenes; Indoles; Interleukin-6; Mice; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pituitary Gland, Anterior; Protein Kinase C; Pyrroles; Pyrrolidinones; Receptor, Adenosine A2B; Type C Phospholipases; Vascular Endothelial Growth Factors; Wortmannin | 2003 |